These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 1031051)

  • 1. [Behavior of various endocrine and metabolic parameters in heart patients treated with glucagon].
    Gragnoli G; Martinelli G; Nami R; Tanganelli I; Favilli R; Palazzuoli V; pallassini A
    Boll Soc Ital Cardiol; 1976; 21(5):834-55. PubMed ID: 1031051
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of heart failure using zinc-protamine-glucagon].
    Kühn P
    Z Kardiol; 1973 Aug; 62(8):728-40. PubMed ID: 4779156
    [No Abstract]   [Full Text] [Related]  

  • 3. [Metabolic effect of glucagon in chronic cardiac insufficiency].
    Franke F; Berchthold P; Simon H
    Med Welt; 1972 Oct; 23(41):1421-3. PubMed ID: 5087189
    [No Abstract]   [Full Text] [Related]  

  • 4. [Zinc-protamine-glucagon in the therapy of heart failure].
    Kaindl F; Kühn P
    Z Gesamte Inn Med; 1972 Dec; 27(24):1097-8. PubMed ID: 4654564
    [No Abstract]   [Full Text] [Related]  

  • 5. [Role of insulin and counter-regulatory hormones in the metabolic changes caused by insulin deprivation in diabetic patients].
    Castillo MJ; Scheen AJ; Gualda P; Lefebvre PJ
    Rev Esp Fisiol; 1989 Mar; 45(1):53-9. PubMed ID: 2664924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of glucagon in heart decompensation].
    Battaglia A; Mercurio G; Profeta F; Gnoffo R; Raineri A
    Boll Soc Ital Cardiol; 1973; 18(12):1231-40. PubMed ID: 4807044
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of glucagon in heart decompensation: personal case reports].
    Del Giallo P; Magini G; Valiensi M; Lombardi M
    Boll Soc Ital Cardiol; 1972; 17(12):1194-203. PubMed ID: 4681444
    [No Abstract]   [Full Text] [Related]  

  • 8. [Glucagon in the therapy of cardiac insufficiency. Clinical study of 50 treated cases].
    Lotto A; Sanna GP; Bomanto B; Bossi M; Rota M
    G Ital Cardiol; 1973; 3(3):405-13. PubMed ID: 4766974
    [No Abstract]   [Full Text] [Related]  

  • 9. [Active chronic hepatitis and insulin resistance: possible role of glucagon, GH and free fatty acids].
    Bonora E; Coscelli C; Orioli S; Cambi R; Buzzelli G; Gentilini P; Butturini U
    G Clin Med; 1981 Dec; 62(12):831-45. PubMed ID: 7042433
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of glucagon in the therapy of cardiac insufficiency].
    Artese D; Di Nicola A; Santilli S
    Minerva Cardioangiol; 1976 Feb; 24(2):155-60. PubMed ID: 1256655
    [No Abstract]   [Full Text] [Related]  

  • 11. [Glucagon as a life-saving drug].
    De Thomatis M
    Minerva Cardioangiol; 1973 Dec; 21(12):845-53. PubMed ID: 4780274
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolic modulation by concomitant administration of insulin and glucagon in pancreatectomy patients.
    Tanjoh K; Tomita R; Mera K; Hayashi N
    Hepatogastroenterology; 2002; 49(44):538-43. PubMed ID: 11995491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of recombinant human growth hormone on catabolic hormones and free fatty acids following thermal injury.
    Fleming RY; Rutan RL; Jahoor F; Barrow RE; Wolfe RR; Herndon DN
    J Trauma; 1992 Jun; 32(6):698-702; discussion 702-3. PubMed ID: 1613829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiac action of glucagon in patients with heart diseases].
    Hermann HJ; Sanmarco ME; Meyers SN
    Prensa Med Argent; 1971 Jul; 58(22):1079-85. PubMed ID: 5097750
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic action of glucagon on pathological states of the myocardium, especially on specific conduction tissue disorders].
    Sanna S; Leo P; Netter R
    Boll Soc Ital Cardiol; 1975; 20(10):1233-49. PubMed ID: 1234422
    [No Abstract]   [Full Text] [Related]  

  • 16. [Glucagon in circulatory failure of coronary origin refractory to digitalis treatment].
    Szmydt W; Kozlowska F; Krug H
    Kardiol Pol; 1975; 18(2):191-6. PubMed ID: 1133895
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of subcutaneous insulin infusions on the metabolic regulation in unstable diabetics].
    Keller U; Viollier E; Schwarz U; Girard J; Berger W
    Schweiz Med Wochenschr; 1980 Nov; 110(47):1754-60. PubMed ID: 7006075
    [No Abstract]   [Full Text] [Related]  

  • 18. Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy.
    Nikolaidis LA; Elahi D; Hentosz T; Doverspike A; Huerbin R; Zourelias L; Stolarski C; Shen YT; Shannon RP
    Circulation; 2004 Aug; 110(8):955-61. PubMed ID: 15313949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Glucagon. A new cardioactive drug].
    Guerricchio G
    Minerva Med; 1974 Oct; 65(72):3799-803. PubMed ID: 4607692
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cardiotonic effects of glucagon].
    Robert M; Humair L
    Schweiz Med Wochenschr; 1970 Aug; 100(31):1345-52. PubMed ID: 5513359
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.